2B77.DE vs. XGEN.DE
2B77.DE (iShares Ageing Population UCITS ETF) and XGEN.DE (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both Health & Biotech Equities funds - 2B77.DE tracks the iSTOXX® FactSet Ageing Population while XGEN.DE tracks the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. Both are passively managed. Over the past 3 years, 2B77.DE returned 10.94%/yr vs 1.39%/yr for XGEN.DE. A 0.74 correlation means they provide meaningful diversification when combined. 2B77.DE charges 0.40%/yr vs 0.30%/yr for XGEN.DE.
Performance
2B77.DE vs. XGEN.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 2B77.DE achieves a 2.83% return, which is significantly higher than XGEN.DE's -1.40% return.
2B77.DE
- 1D
- 1.81%
- 1M
- 0.31%
- YTD
- 2.83%
- 6M
- 4.39%
- 1Y
- 16.72%
- 3Y*
- 10.94%
- 5Y*
- 5.15%
- 10Y*
- —
XGEN.DE
- 1D
- 3.92%
- 1M
- 6.45%
- YTD
- -1.40%
- 6M
- -3.78%
- 1Y
- 22.37%
- 3Y*
- 1.39%
- 5Y*
- —
- 10Y*
- —
2B77.DE vs. XGEN.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
2B77.DE iShares Ageing Population UCITS ETF | 2.83% | 13.27% | 14.30% | 5.16% | -1.35% |
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -1.40% | 7.38% | 2.95% | -5.84% | -9.98% |
Correlation
The correlation between 2B77.DE and XGEN.DE is 0.69, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.69 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.72 |
Correlation (All Time) Calculated using the full available price history since Jul 20, 2022 | 0.74 |
The correlation between 2B77.DE and XGEN.DE has been stable across timeframes, ranging from 0.69 to 0.74 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B77.DE vs. XGEN.DE — Risk / Return Rank
2B77.DE
XGEN.DE
2B77.DE vs. XGEN.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Ageing Population UCITS ETF (2B77.DE) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| 2B77.DE | XGEN.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.13 | ||
| Sortino ratioReturn per unit of downside risk | +0.14 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.21 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 2.45 | 1.49 | +0.96 |
| Martin ratioReturn relative to average drawdown | 8.32 | 3.61 | +4.71 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| 2B77.DE | XGEN.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.36 | 1.23 | +0.13 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.34 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | -0.11 | +0.53 |
Drawdowns
2B77.DE vs. XGEN.DE - Drawdown Comparison
The maximum 2B77.DE drawdown since its inception was -38.47%, roughly equal to the maximum XGEN.DE drawdown of -37.58%. Use the drawdown chart below to compare losses from any high point for 2B77.DE and XGEN.DE.
Loading charts...
Drawdown Indicators
| 2B77.DE | XGEN.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.47% | -37.58% | -0.89% |
Max Drawdown (1Y)Largest decline over 1 year | -6.80% | -14.99% | +8.19% |
Max Drawdown (3Y)Largest decline over 3 years | -20.07% | -28.21% | +8.14% |
Max Drawdown (5Y)Largest decline over 5 years | -20.07% | — | — |
Current DrawdownCurrent decline from peak | -1.60% | -14.86% | +13.26% |
Average DrawdownAverage peak-to-trough decline | -5.47% | -19.44% | +13.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.01% | 6.19% | -4.18% |
Volatility
2B77.DE vs. XGEN.DE - Volatility Comparison
The current volatility for iShares Ageing Population UCITS ETF (2B77.DE) is 3.36%, while Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) has a volatility of 6.48%. This indicates that 2B77.DE experiences smaller price fluctuations and is considered to be less risky than XGEN.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 2B77.DE | XGEN.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.36% | 6.48% | -3.12% |
Volatility (6M)Calculated over the trailing 6-month period | 9.17% | 13.73% | -4.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 12.28% | 18.19% | -5.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.09% | 18.66% | -3.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.52% | 18.66% | -2.14% |
2B77.DE vs. XGEN.DE - Expense Ratio Comparison
2B77.DE has a 0.40% expense ratio, which is higher than XGEN.DE's 0.30% expense ratio.
Dividends
2B77.DE vs. XGEN.DE - Dividend Comparison
Neither 2B77.DE nor XGEN.DE has paid dividends to shareholders.
Frequently Asked Questions
2B77.DE and XGEN.DE have a correlation of 0.69, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XGEN.DE is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XGEN.DE is cheaper with a 0.30% expense ratio, compared with 0.40% for 2B77.DE.
2B77.DE tracks iSTOXX® FactSet Ageing Population, while XGEN.DE tracks MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. They also come from different issuers: iShares and Xtrackers. Their fees differ too: 0.40% for 2B77.DE and 0.30% for XGEN.DE.
Find the right allocation for 2B77.DE and XGEN.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer